scholarly journals Biometal muscle to restore atrial transport function in a permanent atrial fibrillation animal model: a potential tool in the treatment of end-stage heart failure

2010 ◽  
Vol 37 (4) ◽  
pp. 870-874 ◽  
Author(s):  
Piergiorgio Tozzi ◽  
Daniel Hayoz ◽  
Steven Taub ◽  
Mirza Muradbegovic ◽  
Elena Rizzo ◽  
...  
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Animal Model ◽  
Transport Function ◽  
Permanent Atrial Fibrillation ◽  
End Stage Heart Failure ◽  
End Stage ◽  
Potential Tool

scholarly journals Catheter ablation for atrial fibrillation in patients with end‐stage heart failure and eligibility for heart transplantation

2020 ◽  
Author(s):  
Christian Sohns ◽  
Nassir F. Marrouche ◽  
Angelika Costard‐Jäckle ◽  
Samuel Sossalla ◽  
Leonard Bergau ◽  
...  
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Catheter Ablation ◽  
Heart Transplantation ◽  
End Stage Heart Failure ◽  
End Stage

Safety of Outpatient Milrinone Infusion in End-Stage Heart Failure: ICD-Level Data on Atrial Fibrillation and Ventricular Tachyarrhythmias

2020 ◽  
Vol 133 (7) ◽  
pp. 857-864
Author(s):  
Ahmed A. Harhash ◽  
James Cassuto ◽  
Ahmed Hussein ◽  
Emmanuel Achu ◽  
Mark J. Zucker ◽  
...  
Keyword(s):  
Heart Failure ◽  
Atrial Fibrillation ◽  
Ventricular Tachyarrhythmias ◽  
Level Data ◽  
End Stage Heart Failure ◽  
End Stage

scholarly journals Large animal model of functional tricuspid regurgitation in pacing induced end-stage heart failure

2017 ◽  
Vol 24 (6) ◽  
pp. 905-910 ◽  
Author(s):  
Marcin Malinowski ◽  
Alistair G. Proudfoot ◽  
David Langholz ◽  
Lenora Eberhart ◽  
Michael Brown ◽  
...  
Keyword(s):  
Heart Failure ◽  
Animal Model ◽  
Tricuspid Regurgitation ◽  
Large Animal Model ◽  
Large Animal ◽  
Functional Tricuspid Regurgitation ◽  
End Stage Heart Failure ◽  
End Stage

Localization of endothelial nitric oxide synthase in the normal and failing human atrial myocardium

1996 ◽  
Vol 54 ◽  
pp. 786-787
Author(s):  
Chi-Ming Wei ◽  
Margarita Bracamonte ◽  
Shi-Wen Jiang ◽  
Richard C. Daly ◽  
Christopher G.A. McGregor ◽  
...  
Keyword(s):  
Nitric Oxide ◽  
Heart Failure ◽  
Nitric Oxide Synthase ◽  
Endothelial Nitric Oxide Synthase ◽  
Cardiac Tissues ◽  
Mammalian Tissues ◽  
End Stage Heart Failure ◽  
End Stage ◽  
Oxide Synthase ◽  
Endothelial Nitric Oxide

Nitric oxide (NO) is a potent endothelium-derived relaxing factor which also may modulate cardiomyocyte inotropism and growth via increasing cGMP. While endothelial nitric oxide synthase (eNOS) isoforms have been detected in non-human mammalian tissues, expression and localization of eNOS in the normal and failing human myocardium are poorly defined. Therefore, the present study was designed to investigate eNOS in human cardiac tissues in the presence and absence of congestive heart failure (CHF).Normal and failing atrial tissue were obtained from six cardiac donors and six end-stage heart failure patients undergoing primary cardiac transplantation. ENOS protein expression and localization was investigated utilizing Western blot analysis and immunohistochemical staining with the polyclonal rabbit antibody to eNOS (Transduction Laboratories, Lexington, Kentucky).

562 The clinical improvement of end-stage heart failure is not accompanied by correction of anemia

2006 ◽  
Vol 5 (1) ◽  
pp. 126-126
Author(s):  
S DRAKOS ◽  
E KALDARA ◽  
M BONIOS ◽  
D KARAGEORGOPOULOS ◽  
C PIERRAKOS ◽  
...  
Keyword(s):  
Heart Failure ◽  
Clinical Improvement ◽  
End Stage Heart Failure ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document